Singapore markets open in 2 hours 5 minutes
Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,187.70 +6.96 (+0.13%) Dow
38,884.26 +31.99 (+0.08%) Nasdaq
16,332.56 -16.69 (-0.10%) Bitcoin USD
62,898.73 -574.60 (-0.91%) CMC Crypto 200
1,306.97 -58.16 (-4.26%)
Oncolytics Biotech Inc. (ONCY)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 88.68M |
| Enterprise value | 63.49M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.43 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -1.90 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.46 |
| 52-week change 3 | -27.61% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 3.3900 |
| 52-week low 3 | 0.8800 |
| 50-day moving average 3 | 1.0702 |
| 200-day moving average 3 | 1.5496 |
Share statistics
| Avg vol (3-month) 3 | 321.54k |
| Avg vol (10-day) 3 | 144.92k |
| Shares outstanding 5 | 75.42M |
| Implied shares outstanding 6 | 75.46M |
| Float 8 | 68.37M |
| % held by insiders 1 | 3.90% |
| % held by institutions 1 | 6.76% |
| Shares short (15 Apr 2024) 4 | 928.07k |
| Short ratio (15 Apr 2024) 4 | 3.41 |
| Short % of float (15 Apr 2024) 4 | 1.31% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.23% |
| Shares short (prior month 15 Mar 2024) 4 | 919.71k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 25 May 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 10:95 |
| Last split date 3 | 25 May 2018 |
Financial highlights
Currency in CAD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -55.47% |
| Return on equity (ttm) | -102.66% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -33.71M |
| Net income avi to common (ttm) | -27.75M |
| Diluted EPS (ttm) | -0.3000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 34.91M |
| Total cash per share (mrq) | 0.46 |
| Total debt (mrq) | 423k |
| Total debt/equity (mrq) | 1.54% |
| Current ratio (mrq) | 9.01 |
| Book value per share (mrq) | 0.37 |
Cash flow statement
| Operating cash flow (ttm) | -28.45M |
| Levered free cash flow (ttm) | -18M |
© 2024 Yahoo. All rights reserved.